Avantor, Inc. (VIE:AVTR)
9.65
-0.30 (-3.02%)
Last updated: Dec 4, 2025, 1:00 PM CET
Revenue Breakdown
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Laboratory Solutions Revenue | 4.41B | 4.61B |
Log In |
Log In |
Log In | Upgrade
|
| Bioscience Production Revenue | 2.17B | 2.17B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.58B | 6.78B |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Americas Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Europe Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Other) | 6.58B | 6.78B |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.58B | 6.78B |
Log In |
Log In |
Log In | Upgrade
|
Revenue Breakdown 2
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Proprietary Materials & Consumables Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Third Party Materials & Consumables Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Services & Specialty Procurement Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Equipment & Instrumentation Revenue | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Revenue (Total) | 6.58B | 6.78B |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBIT
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Laboratory Solutions Adjusted Operating Income | 543.30M | 598.00M |
Log In |
Log In |
Log In | Upgrade
|
| Bioscience Production Adjusted Operating Income | 540.00M | 558.20M |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted Operating Income | -71.60M | -66.40M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | -407.80M | -451.60M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 603.90M | 638.20M |
Log In |
Log In |
Log In | Upgrade
|
Adjusted EBITDA by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2017 - 2020 |
| Americas Adjusted EBITDA | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Europe Adjusted EBITDA | - | - |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Adjusted EBITDA | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Corporate Adjusted EBITDA | - | - |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Other) | 603.90M | 638.20M |
Log In |
Log In |
Log In | Upgrade
|
| Operating Income (Total) | 603.90M | 638.20M |
Log In |
Log In |
Log In | Upgrade
|
Capital Expenditures by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2016 - 2019 |
| Americas Capital Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|
| Europe Capital Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|
| AMEA Capital Expenditures | - |
Log In |
Log In |
Log In | Upgrade
|